Perseus Soros Biopharmaceutical Fund Lp

Avg. Two Year Performance

201% Avg. Purchase Return
73% Compound
(34%) Avg. Sale Return
(16%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return26%5%11%51%201%
Purchase Success Rate1 of 22 of 22 of 21 of 22 of 2
Average Sale Return(< 1%)19%(< 1%)(10%)(34%)
Sale Success Rate1 of 22 of 21 of 21 of 20 of 2

Urigen Pharmaceuticals, Inc.

Other » Other

10% Owner:

Holdings: 2.17M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Barrier Therapeutics Inc.

Drugs » Biotechnology

10% Owner:

Holdings: 2.32M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

MAP Pharmaceuticals, Inc.

Drugs » Drug Manufacturers - Other

10% Owner:

Holdings: 1.83M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--